Precigen IncPGEN
Price$8.21

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $31.6M+1,635.0% YoYTTM through 31 Mar 2026
Net Income -$204.4MTTM through 31 Mar 2026
Free Cash Flow -$89.8MTTM through 31 Mar 2026

Margins

Current
Gross Margin87.7%
Operating Margin-25.8%
Net Margin-34.1%

Returns

-39.2%ROE
-5.7%ROA

Balance Sheet Health

Debt / Equity4.86x
Current Ratio4.82x
Net Debt$41.6M
Cash & Equivalents$7.5M

Quality Metrics

FCF Margin-284.3%
Earnings-Beat Rate75.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
PAPZIMEOS Product Sales$21.6M
View details

Strong continued launch momentum expected in Q2 2026 and beyond, supported by a permanent J-code (J3404) effective April 1, 2026, and broad payer coverage of approximately 297 million US insured lives.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.